News Quantified

SNSE – sensei biotherapeutics, inc. (US:NASDAQ)

Sensei Biotherapeutics (NASDAQ:SNSE) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.

11/14

07:30 am

snse

Medium

Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results

Sensei Biotherapeutics (NASDAQ:SNSE) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating.

Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value [Yahoo! Finance]

Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value

Live Event: Join our next subscriber-only event: "The Data Driven Investor"

Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}